Targeting the NMDA Receptor Subunit NR2B for the Treatment of Neuropathic Pain

Neurotherapeutics

Volumn 6, Issue 4, 2009, Pages 693-702

  Wu, Long Jun ^a   Zhuo, Min ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Seoul National University   (South Korea)

Author keywords

anterior cingulated cortex; glutamate; Neuropathic pain; NMDA receptor; NR2B subunit; Ro25 6981

Indexed keywords

BESONPRODIL; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PERZINFONTEL; RO 256981; TRAXOPRODIL; UNCLASSIFIED DRUG;

ARTICLE; LEARNING; MEMORY; NERVE CELL PLASTICITY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; SPINAL GANGLION;

ANIMALS; CHRONIC DISEASE; GANGLIA, SPINAL; GYRUS CINGULI; HUMANS; MODELS, NEUROLOGICAL; NEURAL PATHWAYS; NEURALGIA; NEURONAL PLASTICITY; PERIPHERAL NERVOUS SYSTEM DISEASES; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 70349331070     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2009.07.008     Document Type: Article

References (88)

1. Wu M., Pang Z., Zhuo M., and Xu Z. Prolonged membrane potential depolarization in cingulate pyramidal cells after digit amputation in adult rats. Mol Pain 1 (2005) 23
2. Zhuo M. Neuronal mechanism for neuropathic pain. Mol Pain 3 (2007) 14
3. Zhuo M. Glutamate receptors and persistent pain: targeting forebrain NR2B subunits. Drug Discov Today 7 (2002) 259-267
4. Chizh B.A., Headley P.M., and Tzschentke T.M. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22 (2001) 636-642
5. Childers Jr. W.E., and Baudy R.B. N-methyl-d-aspartate antagonists and neuropathic pain: the search for relief. J Med Chem 50 (2007) 2557-2562
6. Petrenko A.B., Yamakura T., Baba H., and Shimoji K. The role of N-methyl-d-aspartate (NMDA) receptors in pain: a review. Anesth Analg 97 (2003) 1108-1116
7. Collingridge G.L., and Bliss T.V. Memories of NMDA receptors and LTP. Trends Neurosci 18 (1995) 54-56
8. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11 (2001) 327-335
9. Chatterton J.E., Awobuluyi M., Premkumar L.S., et al. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415 (2002) 793-798
10. Malenka R.C., and Bear M.F. LTP and LTD: an embarrassment of riches. Neuron 44 (2004) 5-21
11. Benke D., Wenzel A., Scheuer L., Fritschy J.M., and Mohler H. Immunobiochemical characterization of the NMDA-receptor subunit NR1 in the developing and adult rat brain. J Recept Signal Transduct Res 15 (1995) 393-411
12. Laurie D.J., Bartke I., Schoepfer R., Naujoks K., and Seeburg P.H. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res Mol Brain Res 51 (1997) 23-32
13. Liu H., Mantyh P.W., and Basbaum A.I. NMDA-receptor regulation of substance P release from primary afferent nociceptors. Nature 386 (1997) 721-724
14. Marvizón J.C., McRoberts J.A., Ennes H.S., et al. Two N-methyl-d-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J Comp Neurol 446 (2002) 325-341
15. Karlsson U., Sjödin J., Angeby Möller K., Johansson S., Wikström L., and Näsström J. Glutamate-induced currents reveal three functionally distinct NMDA receptor populations in rat dorsal horn: effects of peripheral nerve lesion and inflammation. Neuroscience 112 (2002) 861-868
16. Watanabe M., Inoue Y., Sakimura K., and Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3 (1992) 1138-1140
17. Boyce S., Wyatt A., Webb J.K., et al. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 38 (1999) 611-623
18. Miki K., Zhou Q.Q., Guo W., et al. Changes in gene expression and neuronal phenotype in brain stem pain modulatory circuitry after inflammation. J Neurophysiol 87 (2002) 750-760
19. Dracheva S., Byne W., Chin B., and Haroutunian V. Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia. Brain Res 1214 (2008) 23-34
20. Monyer H., Burnashev N., Laurie D.J., Sakmann B., and Seeburg P.H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 (1994) 529-540
21. Zhuo M. Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol Brain 2 (2009) 4
22. Woolf C.J., and Salter M.W. Neuronal plasticity: increasing the gain in pain. Science 288 (2000) 1765-1769
23. Ji R.R., Kohno T., Moore K.A., and Woolf C.J. Central sensitization and LTP: do pain and memory share similar mechanisms?. Trends Neurosci 26 (2003) 696-705
24. Sandkühler J. Understanding LTP in pain pathways. Mol Pain 3 (2007) 9
25. Wei F., Vadakkan K.I., Toyoda H., et al. Calcium calmodulin-stimulated adenylyl cyclases contribute to activation of extracellular signal-regulated kinase in spinal dorsal horn neurons in adult rats and mice. J Neurosci 26 (2006) 851-861
26. Qu X.X., Cai J., Li M.J., et al. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain. Exp Neurol 215 (2009) 298-307
27. Pedersen L.M., and Gjerstad J. Spinal cord long-term potentiation is attenuated by the NMDA-2B receptor antagonist Ro 25-6981. Acta Physiol (Oxf) 192 (2008) 421-427
28. Zhang H.M., Zhou L.J., Hu X.D., Hu N.W., Zhang T., and Liu X.G. Acute nerve injury induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn of intact rat. Sheng Li Xue Bao 56 (2004) 591-596
29. Ikeda H., Stark J., Fischer H., et al. Synaptic amplifier of inflammatory pain in the spinal dorsal horn. Science 312 (2006) 1659-1662
30. Lenz F.A., Gracely R.H., Romanoski A.J., Hope E.J., Rowland L.H., and Dougherty P.M. Stimulation in the human somatosensory thalamus can reproduce both the affective and sensory dimensions of previously experienced pain. Nat Med 1 (1995) 910-913
31. Banati R.B., Cagnin A., Brooks D.J., et al. Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. Neuroreport 12 (2001) 3439-3442
32. Landisman C.E., and Connors B.W. Long-term modulation of electrical synapses in the mammalian thalamus. Science 310 (2005) 1809-1813
33. Carson L.V., Kelahan A.M., Ray R.H., Massey C.E., and Doetsch G.S. Effects of early peripheral lesions on the somatotopic organization of the cerebral cortex. Clin Neurosurg 28 (1981) 532-546
34. Wei F., Qiu C.S., Liauw J., et al. Calcium calmodulin-dependent protein kinase IV is required for fear memory. Nat Neurosci 5 (2002) 573-579
35. Isaac J.T., Crair M.C., Nicoll R.A., and Malenka R.C. Silent synapses during development of thalamocortical inputs. Neuron 18 (1997) 269-280
36. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science 288 (2000) 1769-1772
37. Wei F., Wang G.D., Kerchner G.A., et al. Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4 (2001) 164-169
38. Escobar M.L., Chao V., and Bermúdez-Rattoni F. In vivo long-term potentiation in the insular cortex: NMDA receptor dependence. Brain Res 779 (1998) 314-319
39. Casey K.L. Forebrain mechanisms of nociception and pain: analysis through imaging. Proc Natl Acad Sci U S A 96 (1999) 7668-7674
40. Calejesan A.A., Kim S.J., and Zhuo M. Descending facilitatory modulation of a behavioral nociceptive response by stimulation in the adult rat anterior cingulate cortex. Eur J Pain 4 (2000) 83-96
41. Tang J., Ko S., Ding H.K., Qiu C.S., Calejesan A.A., and Zhuo M. Pavlovian fear memory induced by activation in the anterior cingulate cortex. Mol Pain 1 (2005) 6
42. Wei F., Qiu C.S., Kim S.J., et al. Genetic elimination of behavioral sensitization in mice lacking calmodulin-stimulated adenylyl cyclases. Neuron 36 (2002) 713-726
43. Wei F., Xia X.M., Tang J., et al. Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents. J Neurosci 23 (2003) 8402-8409
44. Liauw J., Wu L.J., and Zhuo M. Calcium-stimulated adenylyl cyclases required for long-term potentiation in the anterior cingulate cortex. J Neurophysiol 94 (2005) 878-882
45. Zhao M.G., Toyoda H., Lee Y.S., et al. Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron 47 (2005) 859-872
46. Wei F., and Zhuo M. Potentiation of sensory responses in the anterior cingulate cortex following digit amputation in the anaesthetised rat. J Physiol 532 (2001) 823-833
47. Zhuo M. Central plasticity in pathological pain. Novartis Found Symp 261 (2004) 132-145 discussion 145-154
48. Paoletti P., and Neyton J. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 7 (2007) 39-47
49. Gogas K.R. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin Pharmacol 6 (2006) 68-74
50. Fischer G., Mutel V., Trube G., et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-d-aspartate receptors containing the NR2B subunit: characterization in vitro. J Pharmacol Exp Ther 283 (1997) 1285-1292
51. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol 44 (1993) 851-859
52. Auberson Y.P., Allgeier H., Bischoff S., Lingenhoehl K., Moretti R., and Schmutz M. 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg Med Chem Lett 12 (2002) 1099-1102
53. Liu L., Wong T.P., Pozza M.F., et al. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304 (2004) 1021-1024
54. Massey P.V., Johnson B.E., Moult P.R., et al. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci 24 (2004) 7821-7828
55. Morishita W., Lu W., Smith G.B., Nicoll R.A., Bear M.F., and Malenka R.C. Activation of NR2B-containing NMDA receptors is not required for NMDA receptor-dependent long-term depression. Neuropharmacology 52 (2007) 71-76
56. Bartlett T.E., Bannister N.J., Collett V.J., et al. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology 52 (2007) 60-70
57. Frizelle P.A., Chen P.E., and Wyllie D.J. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-d-aspartate receptors: Implications for studies of synaptic transmission. Mol Pharmacol 70 (2006) 1022-1032
58. Feng B., Tse H.W., Skifter D.A., Morley R., Jane D.E., and Monaghan D.T. Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Br J Pharmacol 141 (2004) 508-516
59. Wu L.J., Xu H., Ren M., Cao X., and Zhuo M. Pharmacological isolation of postsynaptic currents mediated by NR2A- and NR2B-containing NMDA receptors in the anterior cingulate cortex. Mol Pain 3 (2007) 11
60. Hrabetova S., Serrano P., Blace N., et al. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. J Neurosci 20 (2000) 1-6 RC81
61. Omote K., Kawamata T., Kawamata M., and Namiki A. Formalin-induced release of excitatory amino acids in the skin of the rat hindpaw. Brain Res 787 (1998) 161-164
62. Carlton S.M., and Coggeshall R.E. Inflammation-induced changes in peripheral glutamate receptor populations. Brain Res 820 (1999) 63-70
63. Wilson J.A., Garry E.M., Anderson H.A., et al. NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists. Pain 117 (2005) 421-432
64. Burton A.W., Lee D.H., Saab C., and Chung J.M. Preemptive intrathecal ketamine injection produces a long-lasting decrease in neuropathic pain behaviors in a rat model. Reg Anesth Pain Med 24 (1999) 208-213
65. South S.M., Kohno T., Kaspar B.K., et al. A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain. J Neurosci 23 (2003) 5031-5040
66. Petrenko A.B., Yamakura T., Baba H., and Sakimura K. Unaltered pain-related behavior in mice lacking NMDA receptor GluRε 1 subunit. Neurosci Res 46 (2003) 199-204
67. Malmberg A.B., Gilbert H., McCabe R.T., and Basbaum A.I. Powerful antinociceptive effects of the cone snail venom-derived subtype-selective NMDA receptor antagonists conantokins G and T. Pain 101 (2003) 109-116
68. Terayama R., Guan Y., Dubner R., and Ren K. Activity-induced plasticity in brain stem pain modulatory circuitry after inflammation. Neuroreport 11 (2000) 1915-1919
69. Tang Y.P., Shimizu E., Dube G.R., et al. Genetic enhancement of learning and memory in mice. Nature 401 (1999) 63-69
70. Quintero G.C., Erzurumlu R.S., and Vaccarino A.L. Decreased pain response in mice following cortex-specific knockout of the N-methyl-d-aspartate NR1 subunit. Neurosci Lett 425 (2007) 89-93
71. Wu L.J., Toyoda H., Zhao M.G., et al. Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci 25 (2005) 11107-11016
72. Shum F.W., Wu L.J., Zhao M.G., et al. Alteration of cingulate long-term plasticity and behavioral sensitization to inflammation by environmental enrichment. Learn Mem 14 (2007) 304-312
73. Xu H., Wu L.J., Wang H., et al. Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J Neurosci 28 (2008) 7445-7453
74. Kristensen J.D., Svensson B., and Gordh Jr. T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain 51 (1992) 249-253
75. Brandt M.R., Cummons T.A., Potestio L., Sukoff S.J., and Rosenzweig-Lipson S. Effects of the N-methyl-d-aspartate receptor antagonist perzinfotel [EAA-090; [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid] on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 313 (2005) 1379-1386
76. Baudy R.B., Butera J.A., Abou-Gharbia M.A., et al. Prodrugs of perzinfotel with improved oral bioavailability. J Med Chem 52 (2009) 771-778
77. Chizh B.A., and Headley P.M. NMDA antagonists and neuropathic pain: multiple drug targets and multiple uses. Curr Pharm Des 11 (2005) 2977-2994
78. Hocking G., and Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 97 (2003) 1730-1739
79. Mathisen L.C., Skjelbred P., Skoglund L.A., and Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain 61 (1995) 215-220
80. Nelson K.A., Park K.M., Robinovitz E., Tsigos C., and Max M.B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 48 (1997) 1212-1218
81. Sang C.N., Booher S., Gilron I., Parada S., and Max M.B. Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials. Anesthesiology 96 (2002) 1053-1061
82. Pud D., Eisenberg E., Spitzer A., et al. The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 75 (1998) 349-354
83. Gurwitz D., and Weizman A. The NR2B subunit of glutamate receptors as a potential target for relieving chronic pain: prospects and concerns. Drug Discov Today 7 (2002) 403-406
84. Ko S.W., Wu L.J., Shum F., Quan J., and Zhuo M. Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic tolerance. Mol Brain 1 (2008) 2
85. Narita M., Aoki T., and Suzuki T. Molecular evidence for the involvement of NR2B subunit containing N-methyl-d-aspartate receptors in the development of morphine-induced place preference. Neuroscience 101 (2000) 601-606
86. Nakazato E., Kato A., and Watanabe S. Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model. Pharmacology 73 (2005) 8-14
87. Hutchison W.D., Davis K.D., Lozano A.M., Tasker R.R., and Dostrovsky J.O. Pain-related neurons in the human cingulate cortex. Nat Neurosci 2 (1999) 403-405
88. Köhr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res 326 (2006) 439-446